Q/C Technologies (QCLS) Stock Forecast — 2-Week Outlook

StockMap's current 2-week read on Q/C Technologies (QCLS) is Strong Underperform.

The composite score behind that read is -0.51, weighing +0.00 of bullish evidence against -0.51 bearish.

Q/C Technologies last closed at $0.68, -9.33% on the session.

Against the IVW growth benchmark the position is -10.25% over the forecast window.

The read is built from 11 underlying insights — 0 bullish and 11 bearish.

Agreement across those insights is 100%.

16 graded predictions for QCLS so far. We publish our accuracy across thousands of stocks in the open, misses included — no per-stock hit rate is claimed on a small sample.

On the fundamentals StockMap ranks Q/C Technologies in the 11th percentile on return on equity, where 100 is best.

Q/C Technologies is classified under Health Care / Pharmaceuticals, with a market capitalisation of $6.13M.

StockMap tracks Q/C Technologies as the 114th largest of the 128 companies it covers in the Pharmaceuticals industry, part of the Health Care sector.

Across that group the current two-week reads are 54 Moderate Underperform, 53 Neutral, 15 Strong Underperform and 6 Moderate Outperform.

On that composite Q/C Technologies ranks 117th of 128 in the group, against a group median of -0.24.

Other Health Care stocks

Q/C Technologies (QCLS) — StockMap 2-week forecast & tracked accuracy